Supernus Pharmaceuticals | SUPN - EPS Earnings Per Share


Supernus Pharmaceuticals reported $0.35 in EPS Earnings Per Share for its fiscal quarter ending in September of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2026 1.32 0.59 -0.80 Oct/29
FY2026Q2 Jun/2026 -1.01 0.43 0.40 Aug/03
FY2026Q1 Mar/2026 0.60 0.52 -0.21 May/05
FY2025Q4 Dec/2025 -0.07 0.41 0.27 Feb/24
FY2025Q3 Sep/2025 -0.80 0.37 0.69 Nov/04




Eps Change Date
Abbott USD 0.53 0.78 Sep/2026
ANI Pharmaceuticals USD 2.7 0.49 Sep/2026
Aurora Cannabis CAD -0.07 0.06 Jun/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Canopy Growth CAD -0.03 0.37 Jun/2026
Cara Therapeutics USD -0.72 0.14 Mar/2026
Corcept Therapeutics USD 1.01 0.65 Sep/2026
Eisai JPY 64.71 76.24 Jun/2026
Eli Lilly USD 7.48 0.9 Sep/2026
Novo Nordisk DKK 4.74 6.17 Jun/2026
Pacira USD 0.7 0.03 Sep/2026
Perrigo USD 0.6 0.1 Sep/2026
Pfizer USD 0.87 0.1 Sep/2026
Supernus Pharmaceuticals USD 0.35 1.36 Sep/2026
United Therapeutics USD 5.71 1.56 Sep/2026
Xeris Pharmaceuticals USD -0.18 0.19 Jun/2026